Blalock J E, Weigent D A, Langford M P, Stanton G J
Infect Immun. 1980 Aug;29(2):356-60. doi: 10.1128/iai.29.2.356-360.1980.
Nonsensitized human leukocytes cocultured with various xenogeneic epithelioid and fibroblastic cells produced human leukocyte interferon and shortly thereafter transferred antiviral activity to the xenogeneic cells. Antiviral activity in the cocultured xenogeneic cells was not due to cell-mediated cytotoxicity as measured by specific 51Cr release and staining with vital dyes. The transfer of antiviral activity from leukocytes to xenogeneic cells was blocked by rabbit antiserum to human leukocyte interferon. Transferred viral resistance failed to develop in actinomycin D-treated xenogeneic cells, even though these cells induced human leukocyte interferon. Based on these findings, it appears that interferon made in the cocultures acts on the leukocytes to effect the transfer of interferon-induced viral resistance to the xenogenic cells, possibly by transmission of an inducer for the antiviral state. These studies strongly suggest a new and efficient host defense against virus infection which does not require killing of noninfected or recently infected cells.
与各种异种上皮样细胞和成纤维细胞共培养的未致敏人白细胞产生人白细胞干扰素,此后不久将抗病毒活性转移至异种细胞。共培养的异种细胞中的抗病毒活性并非由通过特异性51Cr释放和活性染料染色所测定的细胞介导的细胞毒性所致。人白细胞干扰素的兔抗血清可阻断抗病毒活性从白细胞向异种细胞的转移。即使经放线菌素D处理的异种细胞可诱导人白细胞干扰素,但转移的病毒抗性仍无法在这些细胞中形成。基于这些发现,似乎共培养中产生的干扰素作用于白细胞,以实现干扰素诱导的病毒抗性向异种细胞的转移,这可能是通过抗病毒状态诱导剂的传递来实现的。这些研究强烈提示了一种新的高效宿主抗病毒感染防御机制,该机制并不需要杀死未感染或近期感染的细胞。